Qingdao Vland Biotech INC. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 514.05 million compared to CNY 534.34 million a year ago. Revenue was CNY 532.6 million compared to CNY 549.1 million a year ago.

Net income was CNY 37.41 million compared to CNY 61.34 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.26 a year ago. Diluted earnings per share from continuing operations was CNY 0.15 compared to CNY 0.26 a year ago.